000057914 001__ 57914
000057914 005__ 20171107095244.0
000057914 0247_ $$2doi$$a10.1155/2013/341269
000057914 0248_ $$2sideral$$a84616
000057914 037__ $$aART-2013-84616
000057914 041__ $$aeng
000057914 100__ $$0(orcid)0000-0003-0349-9997$$aPinilla, I.$$uUniversidad de Zaragoza
000057914 245__ $$aChanges in frequency-doubling perimetry in patients with type i diabetes prior to retinopathy
000057914 260__ $$c2013
000057914 5060_ $$aAccess copy available to the general public$$fUnrestricted
000057914 5203_ $$aPurpose. To evaluate the ability of frequency-doubling technology (FDT) perimetry in detecting visual field defects in young adults with type I diabetes prior to retinopathy or with minor retinovascular changes. Methods. This comparative cross-sectional study included 30 healthy subjects and 73 age-matched patients with type I diabetes mellitus. All subjects underwent a full ocular examination including an FDT with the threshold C-20-5 strategy. Only one eye per subject was randomly included in the statistical analysis. FDT results and time to perform the test were compared between the groups. Results. The mean age was 27.1 years in the control group and 26.6 years in the diabetic group ( ). The mean period from the onset of diabetes was years, while minimal retinovascular changes were observed in 18 eyes. Mean deviation of FDT did not differ between the groups. Although global indices of FDT were within normal limits, pattern standard deviation of FDT was higher in the diabetic group ( ). The area under the receiver operating characteristic curve was 0.647 for pattern standard deviation of FDT (standard error = 0.052; ). Conclusion. FDT can detect retinal dysfunctions in diabetic patients prior to the onset of significant vascular complications.
000057914 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/PI08-0976$$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI11-01239$$9info:eu-repo/grantAgreement/ES/DGA/B99
000057914 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000057914 590__ $$a0.0$$b2013
000057914 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL
000057914 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY
000057914 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000057914 700__ $$0(orcid)0000-0002-2914-2593$$aFerreras, A.$$uUniversidad de Zaragoza
000057914 700__ $$aIdoipe, M.
000057914 700__ $$0(orcid)0000-0002-5621-1937$$aSanchez-Cano, A.$$uUniversidad de Zaragoza
000057914 700__ $$aPerez-Garcia, D.
000057914 700__ $$aHerrera, L.X.
000057914 700__ $$aPinilla, M.J.
000057914 700__ $$aAbecia, E.
000057914 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDepartamento de Cirugía, Ginecología y Obstetricia$$cOftalmología
000057914 7102_ $$12002$$2647$$aUniversidad de Zaragoza$$bDepartamento de Física Aplicada$$cOptica
000057914 773__ $$g2013 (2013), 341269 [7 pp]$$pBioMed res. int.$$tBioMed Research International$$x2314-6133
000057914 8564_ $$s1887175$$uhttps://zaguan.unizar.es/record/57914/files/texto_completo.pdf$$yVersión publicada
000057914 8564_ $$s99389$$uhttps://zaguan.unizar.es/record/57914/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000057914 909CO $$ooai:zaguan.unizar.es:57914$$particulos$$pdriver
000057914 951__ $$a2017-11-07-09:50:05
000057914 980__ $$aARTICLE